Introducing Tapestri Single-cell Multiomics Solution for Multiple Myeloma
Get determinative insights into clonal heterogeneity driving disease progression and therapy response in multiple myeloma, even at its earliest stages.
Providing cancer researchers with the only single-cell technology that simultaneously measures single nucleotide variation (SNV), copy number variation (CNV), and protein data from the same cells. Our multi-omics platform connects genotype and phenotype in each cell, dissecting the architecture of tumors with unprecedented resolution.